Systemic light chain amyloidosis
V Sanchorawala - New England Journal of Medicine, 2024 - Mass Medical Soc
Key Points Systemic Light Chain Amyloidosis Immunoglobulin light chain (AL) amyloidosis
is a rare disease that occurs when a plasma cell disorder produces monoclonal light chains …
is a rare disease that occurs when a plasma cell disorder produces monoclonal light chains …
Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association
Transthyretin amyloid cardiomyopathy (ATTR-CM) results in a restrictive cardiomyopathy
caused by extracellular deposition of transthyretin, normally involved in the transportation of …
caused by extracellular deposition of transthyretin, normally involved in the transportation of …
2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of …
Writing Committee, MM Kittleson, FL Ruberg… - Journal of the American …, 2023 - jacc.org
The systemic amyloidoses are a broad spectrum of diseases that result from misfolding of
proteins that aggregate into b-sheet amyloid fibrils. Over 35 amyloidogenic precursor …
proteins that aggregate into b-sheet amyloid fibrils. Over 35 amyloidogenic precursor …
Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular …
Nearly half of all patients with heart failure (HF) have a normal left ventricular (LV) ejection
fraction (EF) and the condition is termed heart failure with preserved ejection fraction …
fraction (EF) and the condition is termed heart failure with preserved ejection fraction …
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies
A Aimo, M Merlo, A Porcari… - European journal of …, 2022 - Wiley Online Library
Aims An algorithm for non‐invasive diagnosis of amyloid transthyretin cardiac amyloidosis
(ATTR‐CA) and novel disease‐modifying therapies have prompted an active search for CA …
(ATTR‐CA) and novel disease‐modifying therapies have prompted an active search for CA …
ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art Review
JM Griffin, JL Rosenthal, JL Grodin, MS Maurer… - Cardio Oncology, 2021 - jacc.org
Transthyretin cardiac amyloidosis (ATTR-CA) is increasingly diagnosed owing to the
emergence of noninvasive imaging and improved awareness. Clinical penetrance of …
emergence of noninvasive imaging and improved awareness. Clinical penetrance of …
Transthyretin cardiac amyloidosis
A Porcari, M Fontana, JD Gillmore - Cardiovascular Research, 2022 - academic.oup.com
Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized cause of heart
failure (HF) and mortality worldwide. Advances in non-invasive diagnosis, coupled with the …
failure (HF) and mortality worldwide. Advances in non-invasive diagnosis, coupled with the …
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation
M Casali, C Lauri, C Altini, F Bertagna… - Clinical and …, 2021 - Springer
Aim The diagnosis, severity and extent of a sterile inflammation or a septic infection could be
challenging since there is not one single test able to achieve an accurate diagnosis. The …
challenging since there is not one single test able to achieve an accurate diagnosis. The …
JCS 2020 guideline on diagnosis and treatment of cardiac amyloidosis
H Kitaoka, C Izumi, Y Izumiya, T Inomata, M Ueda… - Circulation …, 2020 - jstage.jst.go.jp
[CQ1] What is the role of 99 mTc-PYP scintigraphy (bone scintigraphy) in clinical practice for
CA?∙∙∙∙∙∙ 1655 [CQ2] The role of endomyocardial biopsy. Which site is appropriate for biopsy …
CA?∙∙∙∙∙∙ 1655 [CQ2] The role of endomyocardial biopsy. Which site is appropriate for biopsy …
Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week
M Hanna, FL Ruberg, MS Maurer, A Dispenzieri… - Journal of the American …, 2020 - jacc.org
Technetium-labeled cardiac scintigraphy (ie, Tc-PYP scan) has been repurposed for the
diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM). Validated in cohorts of …
diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM). Validated in cohorts of …